Publications
Showing 1306-1320 from 1626 publications.
- Moreno R, Fernández C, Calvo L, Sanchez-Recalde A, Galeote G, Sánchez-Aquino R, Alfonso F, Macaya C, López-Sendón JL. Meta-analysis comparing the effect of drug-eluting versus bare metal stents on risk of acute myocardial infarction during follow-up.
Am. J. Cardiol. 2007 Mar; 99(5): 621-5
IF: 3.603, Quartile: 1
- Jiménez-Quevedo P, Sabaté M, Angiolillo DJ, Alfonso F, Hernández-Antolín R, Sanmartín M, Gómez-Hospital JA, Bañuelos C, Escaned J, Moreno R, Fernández C, Fernández-Avilés F, Macaya C. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Eur. Heart J. 2007 Aug; 28(16): 1946-52
IF: 9.817, Quartile: 1, Decile: 1
- Tamargo J, Caballero R, Gómez R, Núñez L, Vaquero M, Delpón E. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
Pharmacol. Ther. 2007 Apr; 114(1): 107-26
IF: 7.968, Quartile: 1, Decile: 1
- Badano LP, Gaddi O, Peraldo C, Lupi G, Sitges M, Parthenakis F, Molteni S, Pagliuca MR, Sassone B, Di Stefano P, De Santo T, Menozzi C, Brignole M. Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and left bundle branch block.
Europace 2007 Jan; 9(1): 41-7
IF: 1.376, Quartile: 3
- Sitges M, Teijeira VA, Scalise A, Vidal B, Tamborero D, Collvinent B, Rivera S, Molina I, Azqueta M, Paré C, Brugada J, Mont L. Is there an anatomical substrate for idiopathic paroxysmal atrial fibrillation? A case-control echocardiographic study.
Europace 2007 May; 9(5): 294-8
IF: 1.376, Quartile: 3
- Alfonso F, Bermejo J, Heras M, Segovia J. [Introduction: cardiology: 2006].
Rev Esp Cardiol 2007 Feb; 60 Suppl 1: 1-2
IF: 2.88, Quartile: 2
- Alfonso F, Suárez A, Perez-Vizcayno MJ, Moreno R, Escaned J, Bañuelos C, Jiménez P, Bernardo E, Angiolillo DJ, Hernández R, Macaya C. Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis.
J. Am. Coll. Cardiol. 2007 Nov; 50(21): 2095-7
IF: 11.054, Quartile: 1, Decile: 1
- Carda Barrio R, de Agustín JA, Manzano MC, Garcia-Rubira JC, Fernández-Ortiz A, Vilacosta I, Macaya C. [In-hospital prognostic value of glomerular filtration rate in patients with acute coronary syndrome and a normal creatinine level].
Rev Esp Cardiol 2007 Jul; 60(7): 714-9
IF: 2.88, Quartile: 2
- Sanz-González SM, Barquín L, García-Cao I, Roqué M, González JM, Fuster JJ, Castells MT, Flores JM, Serrano M, Andrés V. Increased p53 gene dosage reduces neointimal thickening induced by mechanical injury but has no effect on native atherosclerosis.
Cardiovasc. Res. 2007 Sep; 75(4): 803-12
IF: 6.127, Quartile: 1, Decile: 1
- Vidal B, Sitges M, Delgado V, Mont L, Díaz-Infante E, Azqueta M, Paré C, Tolosana JM, Berruezo A, Tamborero D, Roig E, Brugada J. [Influence of cardiopathy etiology on responses to cardiac resynchronization therapy].
Rev Esp Cardiol 2007 Dec; 60(12): 1264-71
IF: 2.88, Quartile: 2
- Angiolillo DJ, Bernardo E, Sabaté M, Jiménez-Quevedo P, Costa MA, Palazuelos J, Hernández-Antolín R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Guzman LA, Bass TA, Macaya C, Fernández-Ortiz A. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
J. Am. Coll. Cardiol. 2007 Oct; 50(16): 1541-7
IF: 11.054, Quartile: 1, Decile: 1
- Alfonso F. Immediate coronary imaging for acute chest pain: are we there yet?
J. Am. Coll. Cardiol. 2007 Aug; 50(7): 650-1; author reply 651
IF: 11.054, Quartile: 1, Decile: 1
- Colli A, Josa M, Pomar JL, Mestres CA, Gherli T. Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today?
Cardiology 2007; 108(1): 4-10
IF: 1.701, Quartile: 3
- Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.
Eur. Heart J. 2007 Jan; 28(2): 230-68
IF: 9.817, Quartile: 1, Decile: 1
- Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).
Eur. Heart J. 2007 Oct; 28(19): 2375-414
IF: 9.817, Quartile: 1, Decile: 1
An initiative of
